Rheumatoid arthritis

Immunemed Inc. is engaged in clinical research focused on rheumatoid arthritis, with interest in treatment options for moderate to severe disease and disease activity control in patients who have not responded adequately to prior disease-modifying antirheumatic drugs.

• Inflammatory joint disease
• Autoimmune therapy
• DMARD-refractory rheumatoid arthritis
• Symptom and disease control

The sponsor’s research interest centers on therapies added to existing antirheumatic treatment regimens, reflecting a focus on immune-mediated joint disease and unmet needs in rheumatology.